학술논문

HDAC inhibition enhances MEK antagonist therapy in uveal melanoma through combined blockade of YAP, AKT and RTK signaling
Document Type
Journal
Source
CANCER RESEARCH; JUL 2019, 79 13, 2p. Supplement: S
Subject
Language
English
ISSN
15387445